Sponsor:
Ohio State University Comprehensive Cancer Center
Code:
NCT06949943
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Behavioral Intervention
Behavioral Intervention
Electronic Health Record Review
Survey Administration
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT06949943
Start date
Mar 14, 2025
Status verified date
May, 2026
Completion date
Jul 31, 2027
Anticipated
Primary completion date
Jul 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Arm I (guided meditation)
active comparator: Arm II (noise cancelling headphones)
Interventions
Behavioral Intervention
Behavioral Intervention
Electronic Health Record Review
Survey Administration
Primary outcome measure
Central contacts
Locations
Ohio State University Comprehensive Cancer Center
Recruiting
Columbus, Ohio, United States, 43210
Contacts
Principal Investigator:
Maryanna Klatt, PhD
Sponsor
Ohio State University Comprehensive Cancer Center
Last update posted
May 7, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2026-05-07.